Washington, DC 20006-5349
HELPLINE
[youtube=http://www.youtube.com/watch?v=BD1q6-CC1PE]
Data from a positive phase 2/3 clinical trial evaluating the effectiveness of a drug for mesothelioma was just published in the Journal of the American
Melina Marmarelis, MD, Thoracic Medical Oncologist, UPenn joins us for an interview about precision medicine for mesothelioma. She discusses biomarker information, such as histology (currently
Hair loss, or alopecia, is often associated with cancer therapies and, in particular, with cytotoxic chemotherapy. While this side effect is most often temporary –
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
